/
BTCY
$0.12-$0.01 (-7.43%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.10 – $0.75
4% from low
Exchange
OTC Link
CS
Borrow rate
5.32%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-17.34
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $398.2K | $1.4M | $3.4M | $7.7M | $9.6M | $12.1M | $13.8M |
| Cost of revenue | $0 | $338.3K | $932.0K | $2.1M | $3.1M | $4.2M | $3.7M | $3.2M |
| Gross profit | $0 | $59.9K | $485.8K | $1.3M | $4.6M | $5.4M | $8.4M | $10.6M |
| Gross margin | — | 15.0% | 34.3% | 37.6% | 59.7% | 56.5% | 69.3% | 76.6% |
| R&D | $1.8M | $1.3M | $1.4M | $2.1M | $2.7M | $3.2M | $2.6M | $2.2M |
| Operating income | −$7.7M | −$8.6M | −$10.9M | −$13.2M | −$16.7M | −$15.4M | −$8.8M | −$2.4M |
| EBITDA | $0 | −$8.6M | −$10.8M | −$12.5M | −$18.6M | −$16.1M | −$8.9M | −$3.2M |
| Net income | −$8.6M | −$8.6M | −$11.1M | −$15.5M | −$29.1M | −$18.7M | −$14.1M | −$8.4M |
| Net margin | — | -2157.7% | -780.6% | -457.7% | -380.8% | -193.6% | -116.8% | -61.1% |
| EPS (diluted) | -1.72 | -1.54 | -1.85 | -2.63 | -3.99 | -2.26 | -1.66 | -0.55 |
Annual figures · source: Financial Modeling Prep
Peer comparison
BIOTRICITY INC
BIOTRICITY INC
Held by traders on TradeandTell
No one on the platform currently holds BTCY.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in BTCY as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2023-07-03 | 1-for-6reverse |
Recent trades on TradeandTell
No one on the platform has traded BTCY yet.
